glp 1 and gastric bypass Metabolic Bariatric Surgery vs. GLP-1 Receptor Agonists for Obesity Management The figure represents the major
Description
doi: 10.20452/pamw.16527
VIVUS LCC
Between 20%-50% of weight lost on GLP-1 drugs is muscle loss
Orforglipron received FDA approval under the brand name Foundayo
Some patients report improvement in bloating and urgency, while others experience temporary changes in bowel patterns
While prescription drug costs are going up, total medical and prescription drug spend is trending down
